Novo Nordisk Investigational Site

Ciudad Autónoma de BsAs C1426ABP

0 studies enrolling now · 4 studies all time

What they study most

Congenital Bleeding Disorder, Diabetes, Diabetes Mellitus, Type 2, Haemophilia A, Haemophilia A With Inhibitors, Haemophilia B, Haemophilia B With Inhibitors, Metabolism and Nutrition Disorder, Obesity

Studies at this site

• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes — Completed
• Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds — Completed
• Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin — Completed
• Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia — Completed